Bennett Bryan, Sharma Sanjeev, Rentea Rebecca M.
Henry Ford Allegiance Health
Children's Mercy
Thymectomy, the surgical removal of the thymus gland, is a cornerstone procedure for managing various conditions, including thymic tumors—such as thymomas, thymic carcinomas, and thymic neuroendocrine tumors—and myasthenia gravis (MG). Historically, thymectomy was first performed incidentally by Garre and Sauerbruch during thyroidectomies for Graves disease. However, it was not until Blalock and colleagues demonstrated its utility in managing MG, including in patients without thymomas, that thymectomy gained widespread clinical significance. Advances in surgical techniques have transformed the traditional median sternotomy or transsternal approach, which remains the gold standard, to less invasive alternatives. These include upper partial sternotomy, transcervical approaches, video-assisted thoracoscopic surgery, and robotic-assisted thymectomy. These minimally invasive techniques have demonstrated superior outcomes, including shorter hospital stays and reduced morbidity and mortality. Preoperative imaging is essential for evaluating tumor resectability and determining the need for induction therapy. At the same time, thorough functional and pulmonary assessments guide the surgical plan, particularly in single-lung ventilation for thoracoscopic approaches. This course examines the evolving role of thymectomy in clinical practice, focusing on indications, surgical techniques, and outcomes.
胸腺切除术,即通过手术切除胸腺,是治疗多种疾病的关键手术,包括胸腺肿瘤,如胸腺瘤、胸腺腺癌和胸腺神经内分泌肿瘤,以及重症肌无力(MG)。历史上,胸腺切除术最初是由加勒(Garre)和绍尔布鲁赫(Sauerbruch)在为格雷夫斯病(Graves disease)进行甲状腺切除术时偶然实施的。然而,直到布莱洛克(Blalock)及其同事证明其在治疗重症肌无力(包括无胸腺瘤患者)中的效用后,胸腺切除术才获得广泛的临床意义。手术技术的进步已将传统的正中胸骨切开术或经胸骨入路(这仍然是金标准)转变为侵入性较小的替代方法。这些方法包括上半部分胸骨切开术、经颈入路、电视辅助胸腔镜手术和机器人辅助胸腺切除术。这些微创技术已显示出更好的效果,包括缩短住院时间以及降低发病率和死亡率。术前影像学检查对于评估肿瘤可切除性和确定是否需要诱导治疗至关重要。与此同时,全面的功能和肺部评估指导手术方案,特别是在胸腔镜手术的单肺通气方面。本课程探讨胸腺切除术在临床实践中不断演变的作用,重点关注适应症、手术技术和治疗效果。